| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2075c10c6897b7d9b1db8fc31e381d45 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4076 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
| filingDate |
2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_161ddc0dbc4408a0662e9a1a8a3fdbe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa8d5fdd6bcd403785dda056f85708cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81878e4f4003c51a5434621d5ce0d8f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6defdf2d33e129ca5f851cc3f16fbff0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a141c16a0ca10521121fa26689e0448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a96da516fdfd35732e589fb72c50c20 |
| publicationDate |
2021-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3813806-A1 |
| titleOfInvention |
Methods of treating mitochondrial dysfunction |
| abstract |
This disclosure is directed to methods of treating or preventing mitochondrial dysfunction or mitochondrial disease in a subject comprising administration of probucol, or a pharmaceutically acceptable salt thereof. This disclosure is also directed to methods of diagnosing genetic mitochondrial disease in a subject prior to and in association with said treatment or prevention. This disclosure is also directed to methods of assessing and managing a subject with mitochondrial dysfunction or mitochondrial disease using a composite measurement. |
| priorityDate |
2018-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |